Table 2.
Selected reports on gynecomastia prevalence after treatment with dutasteride (0.5 mg/day)
| Number affected (%) | References |
|---|---|
| 9/813 (1) | 13 |
| 50/2167 (2.3) | 14 |
| 21/1188 (1.8) | 15 |
| 1–1.9% annually of a 569 patient cohort | 16 |
| 7/366 (2) | 17 |
| 0/68 (0) | 2 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.